FREQUENCY AND CLINICAL SIGNIFICANCE OF OCCULT CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS
EHA Library, Jordi Vila-Bou, 54107
TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABINE AND ACLARUBICIN COMBINED WITH G-CSF PRIMING: MORE EFFECTIVE AND LESS TOXIC?
EHA Library, Depei Wu, 54108
QUANTITATIVE ULTRASOUND OF PROXIMAL PHALANXES IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS
EHA Library, Antonia De Matteo, 54109
RELATIONSHIP BETWEEN MTHFR POLYMORPHISM AND SIDE EFFECTS OF HIGH-DOSE METHOTREXATE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Seham Ragab, 54110
INVASIVE FUNGAL INFECTIONS IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA: RESULTS FROM AN UNIVERSITY HOSPITAL, 2005 TO 2013
EHA Library, Zumrut Sahbudak Bal, 54113
ASPARAGINASE-ASSOCIATED PANCREATITIS (AAP) DURING TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EHA Library, Teresa Garrido, 54114
MOLECULAR CYTOGENETIC ANALYSIS IN 108 CHILDHOOD ACUTE LEUKEMIA PATIENTS FROM SAUDI ARABIA: CORRELATION TO MOLECULAR AND OTHER BIOLOGIC FACTORS
EHA Library, Yasser Elborai, 54115
LENALIDOMIDE FOR TREATMENT OF REFRACTORY/RELAPSED ADULT B-ALL PATIENTS: RESULTS OF A MULTICENTRIC PHASE 2 STUDY.
EHA Library, Tavernier-Tardy Emmanuelle, 54116
ENDOCRINE SIDE EFFECTS AFTER CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yesim Oymak, 54117
DECREASE EXPRESSION OF MIR-20A PROMOTES CANCER CELL PROLIFERATION AND PREDICTS POOR SURVIVAL OF ACUTE MYELOID LEUKEMIA
EHA Library, Zhang Nan, 54119
CHARACTERIZATION OF THE RARE TRANSLOCATION T(3;10)(Q26;Q21) IN AN ACUTE MYELOID LEUKEMIA PATIENT
EHA Library, Tereza Jancuskova, 54121
GSX2 DEREGULATION IN CD7+ ACUTE MYELOID LEUKEMIA BEARING 4Q12 TRANSLOCATIONS WITHOUT FUSION GENES
EHA Library, Danika Di Giacomo, 54122
DEVELOPMENT OF MOLECULAR BEACON BASED PCR ASSAY FOR EASY DETECTION AND QUANTIFICATION OF CHIMERIC TRANSCRIPTS OF AML-ETO [T(8;21)] IN ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Rashi Arora, 54125
ANALYSIS OF NPM1 SPLICE VARIANTS REVEALS DIFFERENTIAL EXPRESSION PATTERNS OF PROGNOSTIC VALUE IN ACUTE MYELOID LEUKEMIA
EHA Library, Malgorzata Zajac, 54126
CD123 (IL-3R?) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION
EHA Library, Lorenzo Brunetti, 54128
THE PROGNOSTIC VALUE OF LEUKEMIC STEM CELLS IN PEDIATRIC AML.
EHA Library, Bram De Caluwé, 54129
PSEUDO-EXHAUSTION OF T CELLS IN RELAPSED AML
EHA Library, Felix Lichtenegger, 54131
FREQUENT MUTATIONS IN PML-RARA IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Annette Fasan, 54133
NFATC1 MEDIATES SORAFENIB RESISTANCE IN FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA
EHA Library, Andreas Burchert, 54134
EXPRESSION OF FLT3-ITD DYSREGULATES THE DBC1-SIRT1-P53 SIGNALING AND PROMOTES THERAPY RESISTANCE
EHA Library, Daniel Sasca, 54135
THE COMBINATION OF SELINEXOR (KPT-330), A SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE), & THE FLT3 INHIBITOR QUIZATINIB SHOWS ANTI-TUMOR ACTIVITY IN ACUTE MYELOID LEUKEMIA (AML) IN-VITRO AND IN-VIVO
EHA Library, CHRISTINE CHEN, 54136
CABOZANTINIB IS SELECTIVELY CYTOTOXIC IN ACUTE MYELOID LEUKEMIA CELLS WITH INTERNAL TANDEM DUPLICATION OF FLT3 (FLT3-ITD)
EHA Library, Liang-In Lin, 54137
PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA
EHA Library, Matteo Allegretti, 54138
THE CXCR4 ANTAGONIST BL-8040 SYNERGIZES WITH THE FLT3 INHIBITOR AC220 TO INDUCE APOPTOSIS AND REDUCE MINIMAL RESIDUAL DISEASE OF AML CELLS IN VIVO
EHA Library, Michal Abraham, 54139
VALIDATION OF BI-SPECIFIC T-CELL ENGAGER (BITE®) ANTIBODY ACTIVITY IN VITRO AND IN VIVO AGAINST DIFFERENTIALLY EXPRESSED CELL SURFACE TARGETS IN ACUTE MYELOID LEUKEMIA
EHA Library, Angus Sinclair, 54143
A NOVEL CLEC12AXCD3 BISPECIFIC ANTIBODY EFFICIENTLY INDUCES T-CELL MEDIATED LYSIS OF CLEC12A+ AML BLASTS
EHA Library, Basav Hangalapura, 54144
CELL-TO-CELL COMMUNICATION IN ACUTE MYELOID LEUKEMIA BY TUNNELING NANOTUBES
EHA Library, Maria Omsland, 54146
TIGAR COOPERATES WITH GLYCOLYSIS TO INHIBIT LEUKEMIA CELLS APOPTOSIS AND PREDICTS POOR PROGNOSIS IN PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA
EHA Library, Sixuan Qian, 54147
GLYCOLYSIS INHIBITION ON ACUTE MYELOID LEUKEMIA
EHA Library, Simone Mirabilii, 54148
THE ROS/SUMO AXIS CONTRIBUTES TO ACUTE MYELOID LEUKEMIA CELL RESPONSE TO CHEMOTHERAPEUTIC DRUGS AND CONSTITUTES A POTENTIAL TARGET TO OVERCOME CHEMORESISTANCE
EHA Library, Guillaume Bossis, 54150
THE PROGNOSTIC RELEVANCE OF THE 2008 WHO CLASSIFICATION OF MYELOID NEOPLASMS IN CHILDHOOD ACUTE MYELOID LEUKEMIA
EHA Library, Akitoshi Kinoshita, 54152
REVISITING THE CLONAL DYNAMICS OF TRISOMY 21 AND MONOSOMY 7 MOSAICISM IN CONGENITAL NEUTROPENIA AML
EHA Library, Murat Ünalan, 54153
A SIMPLE AND EFFECTIVE STRATEGY TO DECREASE EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA USING A STREAMLINED SET OF GUIDELINES PAIRED WITH EXPERT SUPPORT.
EHA Library, Anand Jillella, 54154
INCIDENCE AND TYPE OF IDH1 AND IDH2 MUTATIONS IN AML-NK PATIENTS AND THEIR PROGNOSTIC IMPACT ON TREATMENT OUTCOME
EHA Library, Hyeougn-Joon Kim, 54155
THE PROGNOSTIC IMPACT OF CYTOGENETIC AND GENETIC ABNORMALITY FOR THE ACHIEVEMENT OF THE SECOND COMPLETE REMISSION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA.
EHA Library, Keiko Fukunaga, 54159
PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC MARROW TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA BY COMBINEDWT1 EXPRESSION LEVELS AND FLOW CYTOMETRY ASSESMENT
EHA Library, Fabio Guolo, 54161
VALIDATION OF SIE/SIES/GITMO 'FITNESS CRITERIA' FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: APPLICABILITY AND OUTCOME ANALYSIS ACCORDING TO FITNESS AND TO TREATMENT RECEIVED.
EHA Library, Erika BORLENGHI, 54162
Allogeneic hematopoietic stem cell transplantation for patients with core-binding-factor acute myeloid leukemia with c-KIT mutations
EHA Library, Linkun Lee, 54163
ADVERSE PROGNOSTIC IMPACT OF IDH MUTATIONS ON OUTCOME IN ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE
EHA Library, Marijana Virijevic, 54164
ROLE OF INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: KOREAN SOCIETY OF HEMATOLOGY AML/MDS WORKING PARTY KAMS0119 STUDY
EHA Library, Soo-Jeong Kim, 54165
COMBINED USE OF MULTI-COLOR FCM AND PCR ANALYSIS CAN DETECT LESS THAN 0.01% PATHOLOGICAL CELLS IN THE VAST MAJORITY OF DE NOVO AML CASES
EHA Library, Yasuhiro Kazuma, 54166
INDOLEAMINE 2,3-DIOXYGENASE-1 (IDO-1) IS ASSOCIATED WITH HIGH INCIDENCE OF CHEMOREFRACTORY DISEASE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS
EHA Library, Sarah Parisi, 54167
INTEREST OF CYTOGENETIC AND FISH EVALUATION FOR PROGNOSIS EVALUATION IN 198 PATIENTS WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION IN A SINGLE INSTITUTION
EHA Library, Pierre Hirsch, 54169
ACUTE MYELOID LEUKEMIA IN PATIENTS OLDER THAN 75: PROGNOSTIC IMPACT OF FLT3-ITD AND NPM1 MUTATIONS
EHA Library, Pierre Hirsch, 54170
MOLECULAR RELEVANCE OF THE NERVE GROWTH FACTOR RECEPTOR GENE (NTRK1) EXPRESSION IN AML-RELATED MYELOID SARCOMA
EHA Library, Francesca Lazzaroni, 54171
ELN FAVORABLE ACUTE MYELOID LEUKEMIA SHARE THE SAME GOOD PROGNOSIS ACROSS CYTOGENETIC/MOLECULAR SUBGROUPS: PRELIMINARY RETROSPECTIVE REAL-LIFE ANALYSIS OF THE RETE EMATOLOGICA LOMBARDA (REL)
EHA Library, Patrizia Zappasodi, 54172
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
EHA Library, Dario Ferrero, 54173
MDRO INFECTION THE ‘'MAJOR HURDLE TO ACUTE MYELOID LEUKEMIA INDUCTION THERAPY' EXPERIENCE OF A TERTIARY CARE COMPREHENSIVE CANCER CENTER FROM INDIA.
EHA Library, Anupam Chakrapani, 54174
ACQUIRED IDH1 AND IDH2 MUTATIONS IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKAEMIA: THEIR PREVALENCE AND ASSOCIATION WITH OTHER GENE MUTATIONS – A SINGLE CENTRE EXPERIENCE
EHA Library, Gee Fung How, 54175
CLINICAL USEFULNESS OF WT1 MRNA EXPRESSION IN BONE MARROW DETECTED USING A NEW WT1 MRNA ASSAY KIT FOR MONITORING ACUTE MYELOID LEUKEMIA: A COMPARISON WITH PERIPHERAL BLOOD WT1 MRNA EXPRESSIONS
EHA Library, Ken Ishiyama, 54176
MENINGIOMA 1 (MN1) EXPRESSION: REFINED RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS
EHA Library, lamia Ibrahem, 54177
TIME FROM DIAGNOSIS TO TREATMENT (TDT) INITIATION AFFECTS PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) IN YOUNGER ADULTS
EHA Library, Juliana Schuh, 54179
THE IMPACT OF MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN PEDIATRIC PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA ENROLLED IN THE AIEOP AML 2002/01 PROTOCOL.
EHA Library, Martina Pigazzi, 54180
NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS CAN BENEFIT FROM A SIGNIFICANT BETTER SURVIVAL WHEN INCLUDED IN CLINICAL TRIALS
EHA Library, Mauricette Michallet, 54181
COMPARATIVE ANALYSIS OF FOUR COURSES OF STANDARD-DOSE CONSOLIDATION WITHOUT MAINTENANCE VERSUS THREE COURSES OF LOW-INTENSITY CONSOLIDATION WITH MAINTENANCE IN ADULTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Sergey Semochkin, 54183
MN1 OVEREXPRESSION IS A POWERFUL PREDICTOR OF FAILURE OF INDUCTION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIAS SUCH AS CONVENTIONAL CYTOGENETICS AND AGE.
EHA Library, Carlos Rodríguez, 54184
A PHENOTYPIC STUDY OF MONOCLONAL B-CELL LYMPHOCYTOSIS, WITH EMPHASIS ON BIPHENOTYPIC CASES
EHA Library, Ioannis Kostopoulos, 54185
TARGETED ARRAYCGH USED FOR DETERMINING MINIMALLY DELETED REGION ON CHROMOSOME 6Q IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
EHA Library, Marie Jarosova, 54186
INCORPORATION OF NEXT-GENERATION SEQUENCING INTO ATM GENE ANALYSIS IN PATIENTS WITH CLL AND MCL
EHA Library, Veronika Navrkalova, 54187
NOD/SCID GAMMA XENOGRAFT MODEL OF B-CELL MALIGNANCIES USING TP53- AND/OR ATM-DEFICIENT CELL LINES
EHA Library, Jan Verner, 54188
COPY NUMBER ALTERATIONS AND NOTCH1 MUTATIONS PREDICT THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AND NORMAL FISH
EHA Library, Julio Delgado, 54189
CYTOGENETIC EVOLUTION PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, MICHAIL IKSAS, 54193
CHARACTERIZATION AND SIGNIFICANCE OF RARE BALANCED IMMUNOGLOBULIN TRANSLOCATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Florence Van Obbergh, 54194
IMPACT OF TWO CYTOGENETIC LESIONS ON THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Andrea Visentin, 54195
SYSTEMATIC DRUG SENSITIVITY SCREENING IN LYMPHOID MALIGNANCIES IDENTIFIES VULNERABILITIES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH HIGH RISK ABERRATIONS
EHA Library, Leopold Sellner, 54197
TRISOMY 12 IS ASSOCIATED WITH A DISTINCT PATTERN OF LYMPHOCYTOSIS DURING TREATMENT OF CLL WITH IBRUTINIB, WHICH DOES NOT AFFECT RESPONSE DEPTH OR DURATION
EHA Library, Philip Thompson, 54198
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Ilaria Del Giudice, 54199
CD4+CD16- LGL LEUKEMIA SHOWS DISTINCTIVE BIOLOGICAL AND CLINICAL FEATURES
EHA Library, Gregorio Barilà, 54200
DEVELOPMENT AND VALIDATION OF A NOTCH CUSTOM NGS ASSAY FOR IDENTIFYING NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER LYMPHOID MALIGNANCIES
EHA Library, Hsiang-I Liao, 54201
ITALIAN VALIDATION OF THE MDACC PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: ANALYSIS OF 1502 CASES.
EHA Library, Massimo Gentile, 54202
FLUDARABINE, CYCLOPHOSPHAMIDE AND LENALIDOMIDE IN RELAPSED/REFRACTORY PATIENTS WITH CLL, PRELIMINARY RESULTS OF THE PHASE1-2 GIMEMA CLL0606 STUDY.
EHA Library, Francesca Romana Mauro, 54203
A POPULATION BASED EXPERIENCE ON THE USE OF RCD OR RCVP IN AUTOIMMUNE HEMOLYTIC ANEMIA IN CLL
EHA Library, Rajat Kumar, 54205
IMPROVING SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OVER A 40-YEAR PERIOD (1971-2011): A SINGLE INSTITUTION EXPERIENCE
EHA Library, stefano molica, 54207
REDUCTION OF TUMOR LYSIS SYNDROME (TLS) RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS TREATED WITH ABT-199 (GDC-0199): RESULTS OF MODIFICATIONS TO DOSING SCHEDULE AND TLS PROPHYLAXIS
EHA Library, John Seymour, 54208
OPEN LABEL MULTICENTER STUDY OF ELTROMBOPAG FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA SECONDARY TO LYMPHOPROLIFERATIVE DISORDERS
EHA Library, Carlo Visco, 54209
IS ZAP-70 STILL A KEY PROGNOSTIC FACTOR IN EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA? RESULTS OF THE ANALYSIS FROM A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY
EHA Library, Massimo Gentile, 54210
EVALUATION OF IMMUNE RESPONSE TO 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE (PCV13) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA
EHA Library, Jacek Rolinski, 54211
INITIAL CHARACTERISTICS, TREATMENT AND PROGNOSIS ACCORDING TO AGE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A SINGLE-CENTER ANALYSIS BASED ON 949 PATIENTS.
EHA Library, Tycho Baumann, 54212
COMPARATIVE EFFECT OF BENDAMUSTINE PLUS RITUXIMAB (R) VS FLUDARABINE PLUS CYCLOPHOSPHAMIDE PLUS R ON THE LEVELS OF PERIPHERAL BLOOD LEUCOCYTE POPULATIONS IN ADVANCED-STAGE CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Susana Barrena, 54214
EFFICACY AND SAFETY OF BENDAMUSTINE IN COMBINATION WITH RITUXIMAB FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA. AN ITALIAN RETROSPECTIVE MULTICENTER STUDY.
EHA Library, Luca Laurenti, 54215
ANALYSIS OF MERKEL CELL POLYOMAVIRUS PROGNOSTIC SIGNIFICANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Michael Doubek, 54217
A PATHOLOGICAL ABDOMINAL ULTRASONOGRAPHY AT DIAGNOSIS OF CLL SIGNIFICANTLY REDUCES THE TIME TO PROGRESSION IN PATIENTS WITH RAI 0 OR 1 DISEASE
EHA Library, Sara Pezzatti, 54218
IN VITRO COMPARATIVE STUDY ON DIRECT KILLING OF CLL CELLS BY SMALL TARGETED THERAPEUTIC MOLECULES
EHA Library, Sandra Eketorp Sylvan, 54219
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE 'WARNING' RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?
EHA Library, Valentin Garcia-Gutierrez, 54221
SENSOR INTERIM DATA WITH MUTATION ANALYSIS: SWITCHING TO NILOTINIB AFTER MOLECULAR SUBOPTIMAL RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
EHA Library, Kazuhito Yamamoto, 54222
TYROSINE KINASE INHIBITOR (TKI) SWITCHING: EXPERIENCE FROM SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS IN CLINICAL PRACTICE
EHA Library, Rüdiger Hehlmann, 54223
DASATINIB PHARMACOKINETICS AND ITS CORRELATION WITH CLINICAL RESPONSE IN CHRONIC MYELOID LEUKEMIA: A SUBANALYSIS OF THE DARIA-01 STUDY
EHA Library, Kotaro Miyao, 54225
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE MOLECULAR RESPONSE WITH ALPHA-INTERFERON AFTER TREATMENT DISCONTINUATION
EHA Library, Roberto Latagliata, 54226
FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE
EHA Library, A. Emre Eskazan, 54227
LONG-TERM RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL OF HIGH-DOSE IMATINIB WITH OR WITHOUT INTERFERON-α IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
EHA Library, Koji Sasaki, 54228
FOUR-YEAR FOLLOW-UP OF PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA RECEIVING DASATINIB: EFFICACY AND SAFETY
EHA Library, Xiaojun Huang, 54229
ABNORMALITY OF GLUCOSE AND LIPID METABOLISM DURING NILOTINIB THERAPY – RESULTS OF ENIGMA 2 STUDY
EHA Library, Lukas Semerad, 54230
Higher Rate of Major Molecular Response With Nilotinib vs Imatinib in Chinese Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTchina 24-Month Update
EHA Library, Zhi-Xiang Shen, 54231
A NATIONAL EXPERIENCE OF THE USE OF PONATINIB IN PATIENTS FAILING MULTIPLE TYROSINE KINASE INHIBITORS CONFIRMS EFFICACY IN A HEAVILY PRE-TREATED COHORT OF PATIENTS WITH PH+ LEUKAEMIAS
EHA Library, Gareth Gerrard, 54236
OUTCOMES OF THIRD-LINE BCR-ABL1 TYROSINE KINASE INHIBITORS IN THE TREATMENT FAILED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WHO HAVE RECEIVED TWO PRIOR TKIS
EHA Library, Sung-Eun Lee, 54237
PREDICTIVE FACTORS FOR OUTCOME TO NOVEL BCR-ABL1 TYROSINE KINASE INHIBITORS IN IMATINIB FAILED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
EHA Library, Sung-Eun Lee, 54238
OUTCOMES OF PREGNANCY AND THERAPEUTIC APPROACHES IN CHRONIC MYELOID LEUKEMIA DURING PREGNANCY
EHA Library, Ekaterina Chelysheva, 54239

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings